These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 31773416)

  • 1. Atypical Pediatric Demyelinating Diseases of the Central Nervous System.
    Troxell RM; Christy A
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):95. PubMed ID: 31773416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
    Spadaro M; Meinl E
    Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
    Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S
    Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
    Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
    Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
    Dale RC; Brilot F; Banwell B
    Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
    Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
    Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
    Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
    Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.
    Rosenthal JF; Hoffman BM; Tyor WR
    J Investig Med; 2020 Feb; 68(2):321-330. PubMed ID: 31582425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
    Di Pauli F; Berger T
    Front Immunol; 2018; 9():2753. PubMed ID: 30555462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
    Narayan R; Simpson A; Fritsche K; Salama S; Pardo S; Mealy M; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Oct; 25():66-72. PubMed ID: 30048919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.
    Akaishi T; Sato DK; Takahashi T; Nakashima I
    Neurochem Int; 2019 Nov; 130():104319. PubMed ID: 30365980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
    Pohl D
    Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
    Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
    Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice.
    Hennes EM; Baumann M; Lechner C; Rostásy K
    Neuropediatrics; 2018 Feb; 49(1):3-11. PubMed ID: 28859212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children.
    Manguinao M; Krysko KM; Maddike S; Rutatangwa A; Francisco C; Hart J; Chong J; Graves JS; Waubant E
    Mult Scler Relat Disord; 2019 Oct; 35():50-54. PubMed ID: 31319355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Central Nervous System Demyelination-A Novel Disease Entity?
    Weber MS; Derfuss T; Brück W
    JAMA Neurol; 2018 Aug; 75(8):909-910. PubMed ID: 29913011
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic modalities in multiple sclerosis: perspectives in children.
    Chou IJ; Whitehouse WP; Wang HS; Tanasescu R; Constantinescu CS
    Biomed J; 2014; 37(2):50-9. PubMed ID: 24732659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis.
    Cai MT; Zhang YX; Zheng Y; Fang W; Ding MP
    Mult Scler Relat Disord; 2019 Jul; 32():41-45. PubMed ID: 31030018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.